CME

Developing a Treatment for Two Leading Causes of Blindness: dry-AMD and Stargardt Disease-Lessons from a Life Sciences Startup

Developing a Treatment for Two Leading Causes of Blindness: dry-AMD and Stargardt Disease-Lessons from a Life Sciences Startup

Posted by  | CME

When: Wednesday, March 8 from 4:30-5:30 p.m. (with reception to follow) Where: Sheikh Zayed Tower, Room 2119A, Chevy Chase Conference Ctr Featured Speaker: Dr. Josh Boger, Executive Chairman , Alkeus Pharmaceuticals, Inc. Founder, Director and CEO (Former) of Vertex Pharmaceuticals Incorporated About the Speaker: Dr. Joshua Boger is the founder of Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) and(...)

Read More

New Approaches to Metabolomics Research

New Approaches to Metabolomics Research

Posted by  | CME, Research

The Drugs, Biologics, Vaccines and Devices Translational Research Community of the Johns Hopkins Institute for Clinical and Translational Research’s (ICTR) and the Center for Metabolomics Analysis are hosting a symposium Tuesday, March 14 from 9:30 a.m.-noon in the Owens Auditorium in the Koch Cancer Research Building, 1550 Orleans St. Event check-in and coffee service begin at 9(...)

Read More